Title:
INJECTABLE FORMULATION COMPRISING ISOXAZOLINE DERIVATIVE AND METHOD FOR PREPARING SAME
Document Type and Number:
WIPO Patent Application WO/2023/163470
Kind Code:
A1
Abstract:
The present invention relates to an injectable formulation comprising, as an active pharmaceutical ingredient (API), an isoxazoline derivative or a pharmaceutically acceptable salt thereof, which are useful as caspase inhibitors. The injectable formulation according to the present invention can be prepared by mixing a first agent consisting of a high-dose API and a second agent including a reconstituted solution immediately before administered to a patient, and due to stably containing an active API, it is advantageous in that the injectable formulation can be expected to effectively exhibit efficacy when administered to a patient.
More Like This:
Inventors:
BAEK JAEUK (KR)
KIM SUNG WON (KR)
YOON JUNG WOON (KR)
KIM SUNG WON (KR)
YOON JUNG WOON (KR)
Application Number:
PCT/KR2023/002402
Publication Date:
August 31, 2023
Filing Date:
February 20, 2023
Export Citation:
Assignee:
LG CHEMICAL LTD (KR)
International Classes:
A61K9/00; A61K31/4725; A61K47/02; A61K47/40; A61P19/00; A61P29/00
Foreign References:
| KR20060094868A | 2006-08-30 | |||
| KR101829705B1 | 2018-02-19 | |||
| KR20080067705A | 2008-07-21 | |||
| KR20200126928A | 2020-11-09 | |||
| JP2016506936A | 2016-03-07 |
Attorney, Agent or Firm:
KIM, Sung Ho (KR)
Download PDF: